NCT06831981View on ClinicalTrials.gov

Hyperthermia With Chemoradiotherapy in Rectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

September 11, 2024

Primary Completion Date

June 1, 2036

Study Completion Date

March 1, 2037

Conditions
Rectal Cancer
Interventions
OTHER

Hyperthermia

Additional hyperthermia to radiochemotherapy regime in Arm 1 and radiochemotherapy without additional hyperthermia in Arm 2.

RADIATION

Radiotherapy

Radiotherapy of the pelvis

DRUG

Chemotherapy with 5-fluorouracil

Chemotherapy with 5-flurouracil is given in parallel to radiotherapy

DRUG

Consolidation chemotherapy with FOLFOX

Consolidation chemotherapy with 5-fluorouracil and oxaliplatin

Trial Locations (2)

72076

RECRUITING

University Hospital, Tübingen

RECRUITING

Universitätsklinikum Tübingen, Tübingen

All Listed Sponsors
collaborator

University Hospital Erlangen

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

lead

University Hospital Tuebingen

OTHER